Royal Bank of Canada
NRXS icon

Royal Bank of Canada’s Neuraxis NRXS Stock Holding History

Royal Bank of Canada’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4K Sell
500
-9,601
-95% -$70.8K ﹤0.01% 7001
2026
Q1 		$75K Sell
10,101
-5,000
-33% -$27.4K ﹤0.01% 5286
2025
Q4 		$69K Hold
15,101
– – ﹤0.01% 5382
2025
Q3 		$47K Hold
15,101
– – ﹤0.01% 5847
2025
Q2 		$37K Hold
15,101
– – ﹤0.01% 6048
2025
Q1 		$32K Hold
15,101
– – ﹤0.01% 5746
2024
Q4 		$35K Hold
15,101
– – ﹤0.01% 5863
2024
Q3 		$45K Hold
15,101
– – ﹤0.01% 5752
2024
Q2 		$42K Hold
15,101
– – ﹤0.01% 5734
2024
Q1 		$47K Hold
15,101
– – ﹤0.01% 5568
2023
Q4 		$40K Buy
15,101
+14,101
+1,410% +$38.2K ﹤0.01% 6085
2023
Q3 		$4K Buy
+1,000
New +$4.6K ﹤0.01% 6671

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCC
Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $232M AUM 255.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Royal Bank of Canada's NRXS Position: Q2 2026 in Review

Royal Bank of Canada reduced its Neuraxis (NRXS) stake by 95% in Q2 2026, selling an estimated $70.8K and leaving 500 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #7001.

Royal Bank of Canada first reported a position in NRXS in Q3 2023 and has held it in 12 quarters since. The position peaked at $75K in Q1 2026. 32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

  • Royal Bank of Canada held 500 shares of Neuraxis worth $4K as of Q2 2026.
  • Royal Bank of Canada sold 9,601 Neuraxis shares in Q2 2026, an estimated $70.8K.
  • Neuraxis made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7001 holding.
  • Royal Bank of Canada first reported a position in Neuraxis in Q3 2023 and has held it in 12 quarters since.
  • Royal Bank of Canada's Neuraxis position peaked at $75K in Q1 2026.
  • 32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.